首页> 外文期刊>Therapeutic Drug Monitoring >Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method.
【24h】

Determination of sparfloxacin in plasma and urine by a simple and rapid liquid chromatographic method.

机译:用简单快速的液相色谱法测定血浆和尿液中的司帕沙星。

获取原文
获取原文并翻译 | 示例
       

摘要

A simple, specific, sensitive, and rapid method has been developed and validated for the determination of sparfloxacin in human plasma and urine. The assay consisted of reversed-phase HPLC with ultraviolet detection. Plasma proteins were efficiently removed by precipitation with perchloric acid after the addition of grepafloxacin as an internal standard. For the urine samples, the only required sample preparation was dilution. Separation was achieved on a C18 reversed-phase column. The quantification limit was 0.025 mg/L in plasma and 0.5 mg/L in urine. The coefficients of variation (CV) were less than 10% for intra-day and inter-day analyses. The recovery of sparfloxacin added to plasma and urine ranged from 96.7% to 97.9%. The method has been successfully applied to pharmacokinetic studies.
机译:已经开发了一种简单,特异性,灵敏和快速的方法,并已用于测定人血浆和尿液中司帕沙星的有效性。该测定包括具有紫外检测的反相HPLC。加入格列氟沙星作为内标后,用高氯酸沉淀可有效除去血浆蛋白。对于尿液样品,唯一需要的样品制备是稀释。在C18反相色谱柱上完成分离。血浆中的定量限为0.025 mg / L,尿液中的定量限为0.5 mg / L。日内和日间分析的变异系数(CV)小于10%。添加到血浆和尿液中的司帕沙星的回收率为96.7%至97.9%。该方法已成功地应用于药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号